LONDON — In a blow to its cardiovascular aspirations, AstraZeneca said Thursday that its drug for a...
AstraZeneca, Ionis report major trial failure with heart disease drug
LONDON — In a blow to its cardiovascular aspirations, AstraZeneca said Thursday that its drug for a heart disease — one that has become an increasingly...
Author: STAT
Read Original Article